DR 대차 대조표 상태

재무 상태 기준 확인 4/6

DR 의 총 주주 지분은 CN¥6.3B 이고 총 부채는 CN¥240.6M, 이는 부채 대 자기자본 비율을 3.8% 로 가져옵니다. 총자산과 총부채는 각각 CN¥7.1B 및 CN¥845.8M 입니다.

주요 정보

3.8%

부채 비율

CN¥240.58m

부채

이자 보상 비율	n/a
현금	CN¥5.13b
주식	CN¥6.28b
총 부채	CN¥845.80m
총 자산	CN¥7.13b

최근 재무 상태 업데이트

Is DR (SZSE:301177) Weighed On By Its Debt Load?

Oct 29

Is DR (SZSE:301177) A Risky Investment?

Feb 26

Recent updates

Is DR (SZSE:301177) Weighed On By Its Debt Load?

Oct 29

DR's (SZSE:301177) Shareholders Have More To Worry About Than Only Soft Earnings

Sep 05

재무 상태 분석

단기부채: 301177 의 단기 자산 ( CN¥6.2B )이 단기 부채( CN¥765.5M ).

장기 부채: 301177 의 단기 자산( CN¥6.2B )이 장기 부채( CN¥80.3M ).

부채 대 자본 내역 및 분석

부채 수준: 301177 총 부채보다 더 많은 현금을 보유하고 있습니다.

부채 감소: 301177 의 부채 대 자기자본 비율은 지난 5년간 0% 에서 3.8% 로 증가했습니다.

부채 범위: 301177 의 부채는 영업 현금 흐름 ( 113.6% )에 의해 잘 충당되었습니다.

이자 보장: 301177 의 부채에 대한 이자 지급이 EBIT에 의해 잘 충당되었는지 판단할 데이터가 부족합니다.

DR 대차 대조표 상태

재무 상태 기준 확인 4/6

주요 정보

최근 재무 상태 업데이트

Is DR (SZSE:301177) Weighed On By Its Debt Load?

Is DR (SZSE:301177) A Risky Investment?

Recent updates

Consensus EPS estimates fall by 78%

Third quarter 2024 earnings released: CN¥0.032 loss per share (vs CN¥0.059 profit in 3Q 2023)

Is DR (SZSE:301177) Weighed On By Its Debt Load?

DR Corporation Limited to Report Q3, 2024 Results on Oct 30, 2024

DR's (SZSE:301177) Shareholders Have More To Worry About Than Only Soft Earnings

Second quarter 2024 earnings released: EPS: CN¥0.008 (vs CN¥0.11 loss in 2Q 2023)

Subdued Growth No Barrier To DR Corporation Limited's (SZSE:301177) Price

DR Corporation Limited to Report First Half, 2024 Results on Aug 30, 2024

DR (SZSE:301177) Has Announced That Its Dividend Will Be Reduced To CN¥0.50

Dividend reduced to CN¥0.50

DR Corporation Limited, Annual General Meeting, May 28, 2024

DR Corporation Limited, Annual General Meeting, May 28, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

DR Corporation Limited to Report Q1, 2024 Results on Apr 27, 2024

Is DR (SZSE:301177) A Risky Investment?

DR Corporation Limited to Report Fiscal Year 2023 Results on Apr 26, 2024

Consensus EPS estimates fall by 24%

New minor risk - Earnings quality

Third quarter 2023 earnings released: EPS: CN¥0.059 (vs CN¥0.48 in 3Q 2022)

DR Corporation Limited Announces 2022 Cash Dividend (Tax Included), Payable on 20 June 2023

Dr Corporation Limited Approves Cash Dividend for the Year 2022

Now 21% undervalued after recent price drop

High number of new directors

Price target decreased by 19% to CN¥57.62

First quarter 2023 earnings released: EPS: CN¥0.25 (vs CN¥0.94 in 1Q 2022)

Now 20% undervalued

Investor sentiment improved over the past week

Investor sentiment improved over the past week

High number of new directors

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.48 (vs CN¥0.73 in 3Q 2021)

Consensus revenue estimates fall by 10%

Investor sentiment deteriorated over the past week

Second quarter 2022 earnings released: EPS: CN¥0.51 (vs CN¥1.13 in 2Q 2021)

DR Corporation Limited Announces Management Changes

Now 21% undervalued after recent price drop

DR Corporation Limited Announces Final Dividend on A Shares for 2021, Payable on 30 June 2022

Now 21% undervalued after recent price drop

Investor sentiment improved over the past week

DR Corporation Limited Approves Cash Dividend for the Year 2021

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

High number of new and inexperienced directors

DR Corporation Limited, Annual General Meeting, May 20, 2022

DR Corporation Limited Proposes Final Cash Dividend for the Year 2021

Now 22% undervalued after recent price drop

Now 20% undervalued

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

재무 상태 분석

부채 대 자본 내역 및 분석

대차 대조표

건강한 기업 발견하기